Single-Inhaler Triple versus Dual Therapy in Patients with COPD
N Engl J Med
.
2018 Aug 9;379(6):592-593.
doi: 10.1056/NEJMc1807380.
Authors
David A Lipson
1
,
Gerard J Criner
2
,
David A Lomas
3
Affiliations
1
GlaxoSmithKline, Collegeville, PA
[email protected]
2
Lewis Katz School of Medicine at Temple University, Philadelphia, PA
3
University College London, London, United Kingdom
PMID:
30089077
DOI:
10.1056/NEJMc1807380
No abstract available
Publication types
Letter
Comment
MeSH terms
Administration, Inhalation
Bronchodilator Agents*
Humans
Nebulizers and Vaporizers*
Pulmonary Disease, Chronic Obstructive
Substances
Bronchodilator Agents
Grants and funding
MR/N024842/1/MRC_/Medical Research Council/United Kingdom